Estrogen-like activity of aqueous extract from Agrimonia pilosa Ledeb. in MCF-7 cells

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Lee, Young Min ^a   Kim, Jung Bong ^a   Bae, Ji Hyun ^a   Lee, Jong Suk ^b   Kim, Pan Soo ^b   Jang, Hwan Hee ^a   Kim, Haeng Ran ^a  

^a National Institute of Animal Science   (South Korea)

^b Gyeonggi Pharmaceutical Research Center   (South Korea)

Author keywords

Agrimonia pilosa; Estrogenic activity; MCF 7 proliferation assay; Metabolic syndrome

Indexed keywords

AGRIMONIA PILOSA EXTRACT; APIGENIN; APIGENIN GLUCURONIDE; APIGENIN HEXOSE; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GLUCURONIDE; HEXOSE; LUTEOLIN; LUTEOLIN GLUCURONIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

AGRIMONIA; AGRIMONIA PILOSA; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; ESTROGENIC ACTIVITY; FLUORESCENCE POLARIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

AGRIMONIA; CELL PROLIFERATION; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; FLAVONOIDS; HUMANS; MCF-7 CELLS; MENOPAUSE; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84871360453     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-260     Document Type: Article

References (38)

1. Avis NE, Stellato R, Crawford S, Bromberger J, Ganz P, Cain V, Kagawa-Singer M. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnicgroups. Soc Sci Med 2001, 52(3):345-356. 10.1016/S0277-9536(00)00147-7, 11330770.
2. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003, 88(6):2404-2411. 10.1210/jc.2003-030242, 12788835.
3. El-Halawany AM, Chung MH, Ma CM, Komatsua K, Nishihara T, Hattori M. Anti-estrogenic activity of mansorins and mansonones from the heartwood of Mansonia gagei DRUMM. Chem Pharm Bull 2007, 55(9):1332-1337. 10.1248/cpb.55.1332, 17827757.
4. Nordin B, MacGregor J, Smith D. The incidence of osteoporosis in normal women: its relation to age and the menopause. Q J Med 1966, 35(137):25-38.
5. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996, 87(2):20S-26S. 10.1016/0029-7844(95)00431-9, 8559550.
6. Hill K. The demography of menopause. Maturitas 1996, 23(2):113-127. 10.1016/0378-5122(95)00968-X, 8735350.
7. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992, 117(12):1016-1037.
8. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993, 307(6908):836-840. 10.1136/bmj.307.6908.836, 1678884, 8401125.
9. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 1999, 10(4):253-260. 10.1023/A:1008909128110, 10482483.
10. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002, 288(3):321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
11. Davis SR, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in health and disease. Recent Progress in Hormone Research, Proceedings of the 1998 Conference. Volume 54 1999, 185-211. Conn PM.
12. Chan RYK, Chen WF, Dong A, Guo D, Wong MS. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 2002, 87(8):3691-3695. 10.1210/jc.87.8.3691, 12161497.
13. Boué SM, Tilghman SL, Elliott S, Zimmerman MC, Williams K, Payton-Stewart F, Miraflor AP, Howell MH, Shih BY, Carter-Wientjes CH. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology 2009, 150(5):2446-2453. 2671905, 19116342.
14. Miyamoto K, Kishi N, Koshiura R. Antitumor effect of agrimoniin, a tannin of Agrimonia pilosa Ledeb., on transplantable rodent tumors. Jpn J Pharmacol 1987, 43(2):187. 10.1254/jjp.43.187, 3573425.
15. He C, Ji X, Pan Y, Wang H, Wang K, Liang M, Yang L. Antioxidant activity of alcoholic extract of Agrimonia pilosa Ledeb. Med Chem Res 2010, 19(5):448-461.
16. Jung M, Park M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 2007, 12(9):2130-2139. 10.3390/12092130, 17962731.
17. Taira J, Nanbu H, Ueda K. Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264. 7 macrophages. Food Chem 2009, 115(4):1221-1227.
18. Jung CH, Kim JH, Park SJ, Kweon DH, Kim SH, Ko SG. Inhibitory effect of Agrimonia pilosa Ledeb. on inflammation by suppression of iNOS and ROS production. Immunol Invest 2010, 39(2):159-170. 10.3109/08820130903501790, 20136621.
19. Xu X, Qi X, Wang W, Chen G. Separation and determination of flavonoids in Agrimonia pilosa Ledeb. by capillary electrophoresis with electrochemical detection. J Sep Sci 2005, 28(7):647-652. 10.1002/jssc.200400095, 15912734.
20. Murayama T, Kishi N, Koshiura R, Takagi K, Furukawa T, Miyamoto K. Agrimoniin, an antitumor tannin of Agrimonia pilosa Ledeb., induces interleukin-1. Anticancer Res 1992, 12(5):1471-1474.
21. Lee JS, Kim DH, Liu KH, Oh TK, Lee CH. Identification of flavonoids using liquid chromatography with electrospray ionization and ion trap tandem mass spectrometry with an MS/MS library. Rapid Commun Mass Spectrom 2005, 19(23):3539-3548. 10.1002/rcm.2230, 16261653.
22. Yoshida N, Omoto Y, Inoue A, Eguchi H, Kobayashi Y, Kurosumi M, Saji S, Suemasu K, Okazaki T, Nakachi K. Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes. Cancer Sci 2004, 95(6):496-502. 10.1111/j.1349-7006.2004.tb03239.x, 15182430.
23. Jorgensen M, Vendelbo B, Skakkebaek NE, Leffers H. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ Health Perspect 2000, 108(5):403-412. 10.1289/ehp.00108403, 1638061, 10811566.
24. Xing W, Archer TK. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 1998, 12(9):1310-1321. 10.1210/me.12.9.1310, 9731700.
25. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988, 122(3):935-944. 10.1210/endo-122-3-935, 3342760.
26. El-Tanani MKK, Green CD. Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 1997, 60(5-6):269-276.
27. Mueller SO. Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 777(1-2):155-165.
28. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001, 276(40):36869-36872. 10.1074/jbc.R100029200, 11459850.
29. Rasmussen TH, Nielsen JB. Critical parameters in the MCF-7 cell proliferation bioassay (E-Screen). Biomarkers 2002, 7(4):322-336. 10.1080/13547500210132907, 12171759.
30. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 1995, 103:113-122. 1518887, 8593856.
31. Villalobos M, Olea N, Brotons JA, Oleaserrano MF, Dealmodovar JMR, Pedraza V. The E-screen assay: a comparison of different MCF7 cell stocks. Environ Health Perspect 1995, 103(9):844-850. 10.1289/ehp.95103844, 1519213, 7498097.
32. Kato H, Li W, Koike M, Wang Y, Koike K. Phenolic glycosides from Agrimonia pilosa. Phytochemistry 2010, 71(16):1925-1929. 10.1016/j.phytochem.2010.08.007, 20810135.
33. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993, 44(1):37-43.
34. Wilkinson A, Wähälä K, Williamson G. Identification and quantification of polyphenol phytoestrogens in foods and human biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 777(1):93-109. 10.1016/S1570-0232(02)00095-8, 12270203.
35. Verhoog NJ, Joubert E, Louw A. Evaluation of the phytoestrogenic activity of Cyclopia genistoides (honeybush) methanol extracts and relevant polyphenols. J Agric Food Chem 2007, 55(11):4371-4381. 10.1021/jf063588n, 17461595.
36. El-Halawany AM, Chung MH, Nakamura N, Ma CM, Nishihara T, Hattori M. Estrogenic and anti-estrogenic activities of Cassia tora phenolic constituents. Chem Pharm Bull 2007, 55(10):1476-1482. 10.1248/cpb.55.1476, 17917292.
37. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997, 27(1):31-40. 10.1080/01635589709514498, 8970179.
38. Shimizu K, Miyamoto I, Liu J, Konishi F, Kumamoto S, Kondo R. Estrogen-like activity of ethanol extract of Ganoderma lucidum. J Wood Sci 2009, 55(1):53-59.